Skip to content
Forest Global Training Partners
Home Services AI Governance AI Risk Encyclopedia Contact Us
AI Risk Encyclopedia AI Use CasesAI RisksAI Hallucinations Topics Entities Sources
  1. Home
  2. AI Risks
  3. How the FDA Is Using AI to Monitor Drug Advertising and…

AI Risks October 03, 2025 · Pharmacy Times

How the FDA Is Using AI to Monitor Drug Advertising and Ensure Compliance

FDA enhances oversight of drug ads using AI to ensure compliance, addressing risks and benefits in direct-to-consumer advertising.

Read the original at Pharmacy Times ↗

Topics
Regulation & PolicyHealthcareRetail & E-commerceGovernance & Risk Management
Mentions
FDA
Tracked via
“AI Risks”

Related articles

  • The FDA Is Using an AI to "Speed Up" Drug Approvals and Insiders Say It's Making Horrible Mistakes AI Hallucinations · Jul 25, 2025
  • The FDA Is Now Using Agentic AI for Safety Reviews - Tech.co AI Hallucinations · Dec 05, 2025
  • Using AI to Monitor and Enhance Site Health for SEO Success - weareiowa.com AI Use Cases · Aug 08, 2026
  • OpenAI and US FDA hold talks about using AI in drug evaluation, Wired reports AI Risks · May 08, 2025
  • FDA Warning Letter highlights risks of using AI in drug manufacturing | DLA Piper - JD Supra AI Risks · Apr 24, 2026
  • FDA's NewAIGuidance Highlights Risksof Technology, Urges Early Sponsor Engagement AI Risks · Jan 07, 2025

AI Risk Encyclopedia is a curated research index from Forest Global Training Partners. Articles belong to their publishers; we link to and summarize them.

Contact